BIA letter to the Chancellor ahead of the 2019 Spending Round
The BIA has written to the Chancellor ahead of the 2019 Spending Round to highlight how the Government should maintain a competitive life sciences environment in the UK.
Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline.
A new partnership with ARC West London, designed to support innovators across AI, life sciences, robotics and digital industries to scale, bolstering the West London life sciences ecosystem.
It’s Spring Statement week and we have a webinar on what it means for the sector this Friday; also in this blog - why VPAG needs sorting and a new Series C raise for a BIA member, Brainomix.
